These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 18484554
1. Increase of risperidone concentration under chlorprothixene comedication--a case report. Bader W, Greiner C, Haen E. Pharmacopsychiatry; 2008 May; 41(3):116-7. PubMed ID: 18484554 [No Abstract] [Full Text] [Related]
6. Risperidone in schizophrenia: is there a role for therapeutic drug monitoring? Seto K, Dumontet J, Ensom MH. Ther Drug Monit; 2011 Jun; 33(3):275-83. PubMed ID: 21436762 [Abstract] [Full Text] [Related]
7. Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone. Helland A, Habib S, Ulvestad L, Spigset O. J Clin Psychopharmacol; 2018 Jun; 38(3):263-265. PubMed ID: 29613864 [No Abstract] [Full Text] [Related]
8. Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis. Batalla A, Vera M, Torra M, Parellada E. J Clin Psychopharmacol; 2010 Feb; 30(1):92-4. PubMed ID: 20075665 [No Abstract] [Full Text] [Related]
9. Risperidone-associated increase in triglyceride levels. Weinbrenner A, Peus V, Inta D, Englisch S, Zink M. Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019 [No Abstract] [Full Text] [Related]
10. Hyperprolactinemia with low dose of risperidone in a young female. Boothby A, Shad MU. Asian J Psychiatr; 2017 Jun; 27():69-70. PubMed ID: 28558899 [No Abstract] [Full Text] [Related]
11. Pisa syndrome-like peculiar posture occurred while running was successfully improved with risperidone. Harada K, Saito T. Psychiatry Clin Neurosci; 2006 Dec; 60(6):771-2. PubMed ID: 17109715 [No Abstract] [Full Text] [Related]
12. Effects of risperidone on lipid profile. Khalili H, Dashti-Khavidaki S, Okhovatpour H, Ghaeli P. Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072 [No Abstract] [Full Text] [Related]
13. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment. Bozina N, Jovanović N, Lovrić M, Medved V. Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696 [Abstract] [Full Text] [Related]
14. Effects of vitamin D receptor polymorphisms on the risk of schizophrenia and metabolic changes caused by risperidone treatment. Jiang P, Zhu MQ, Li HD, Liu YP, Cai HL, Zhang LM. Psychiatry Res; 2014 Mar 30; 215(3):806-7. PubMed ID: 24418047 [No Abstract] [Full Text] [Related]
19. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1879-83. PubMed ID: 18801405 [Abstract] [Full Text] [Related]
20. Schizophrenia in a 5-year-old. Einfeld SL, Andrews D, Selig R, Williams G, Smith C. Aust N Z J Psychiatry; 2005 Apr 12; 39(4):312. PubMed ID: 15777373 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]